Company news

Imugene Ltd news in 2019

Imugene Ltd's news releases, calls and decks from 2019, newest first.

View company

Imugene Share Placement to raise $24.6 million

December 1, 2019

Imugene Receives $4.13 million R&D Tax Incentive

November 4, 2019

US Defense Grant to Study Imugene CF33 Oncolytic Virotherapy

October 22, 2019

CF33 Oncolytic Virus Clinical Trial Program Update

October 20, 2019

Comprehensive Phase Ib HER-Vaxx Results Presented at ESMO

September 30, 2019

Investor Presentation - Proposed Acquisition

July 14, 2019

New HER-Vaxx Cancer Vaccine trial data presented at ESMO GI

July 7, 2019

Appendix 4C - Quarterly and Business Update

April 15, 2019

IMU presents new mimotope PD-1 vaccine data at AACR

April 2, 2019

IMU presents new KEY-Vaxx and B-Vaxx data at AACR

April 1, 2019

IMU Pre-IND FDA Meeting Provides Guidance for KEY-Vaxx

March 19, 2019

Imugene doses first patient in HER-Vaxx phase 2 trial

March 13, 2019

IMU Announces Presentations on KEY-Vaxx and B-Vaxx at AACR

March 3, 2019

Pause in Trading

February 27, 2019

Decks in 2019